To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C14orf153andKLC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
788 supporting clones for gene C14orf153andKLC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK299527 brain .a 1 to 2505 1 to 2505 T341A C408F tiling clone,   2505/2505
(100 %)
5 diff
(99.9 %id)
DC374451 brain .a 1 to 574 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
EL733344 mixed .a 518 to 1216 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
BM828388 stomach .a 518 to 1053 1 to 536       536/536
(100 %)
0 diff
(100 %id)
TI_1948240779   .a 518 to 1321 127 to 942       816/1315
(62 %)
35 diff
(97.4 %id)
TI_1948240780   .a 518 to 1493 126 to 1099   AAA   974/1275
(76 %)
18 diff
(98.6 %id)
DA142498 alzheimer cortex .a 523 to 1164 2 to 643   capped   642/642
(100 %)
0 diff
(100 %id)
BQ686770 ductal carcinoma, cell line, Pancreas .a 533 to 1315 1 to 785       785/908
(86 %)
7 diff
(99.3 %id)
TI_159678002   .a 535 to 1404 51 to 917       867/1062
(81 %)
15 diff
(98.6 %id)
DA149688 amygdala .a 553 to 1110 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CN292302 embryonic stem cells, cell lines H1, H7, andH9 .a 555 to 1307 1 to 753       753/753
(100 %)
2 diff
(99.8 %id)
BI195860 brain, neuroblastoma .a 586 to 1464 1 to 870       873/872
(100 %)
24 diff
(97.3 %id)
BI197380 brain, neuroblastoma .a 586 to 1458 1 to 879       879/884
(99 %)
37 diff
(95.9 %id)
DA909305   .a 595 to 1166 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA914837   .a 596 to 1162 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CD579285 brain .a 606 to 1337 25 to 755       731/755
(96 %)
8 diff
(99.0 %id)
CX783214 human embryonic stem cells .a 610 to 1399 1 to 790       790/790
(100 %)
1 diff
(99.9 %id)
BQ065939 lymph, lymphoma, cell line .a 624 to 1436 1 to 829       829/1104
(75 %)
22 diff
(98.1 %id)
CN292315 embryonic stem cells, DMSO-treated H9 cellline .a 627 to 1230 1 to 604       604/604
(100 %)
0 diff
(100 %id)
DA068822 cerebellum .a 653 to 1224 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BE264005 lung, small cell carcinoma .a 676 to 1214 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BQ955402 epidermoid carcinoma, cell line, lung .a 676 to 1504 1 to 831   tiling clone,   831/924
(89 %)
3 diff
(99.7 %id)
CF786011 mixed .a 683 to 1411 1 to 728       728/811
(89 %)
13 diff
(98.4 %id)
DA285720 corpus callosum .a 685 to 1177 2 to 494   capped   493/493
(100 %)
0 diff
(100 %id)
DA071138 cerebellum .a 686 to 1238 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA793455 brain .a 695 to 1233 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA517648 brain .a 696 to 1194 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
BQ879716 dorsal root ganglia .a 717 to 1579 1 to 874   AAA   872/881
(98 %)
20 diff
(97.8 %id)
BP266085 thyroid .a 728 to 1307 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CX163152 human embryonic stem cells differentiated toan early endodermal cell type .a 730 to 1570 11 to 851       841/851
(98 %)
0 diff
(100 %id)
DA354792 substantia nigra .a 732 to 1299 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CN292303 embryonic stem cells, DMSO-treated H9 cellline .a 741 to 1486 1 to 746       746/746
(100 %)
0 diff
(100 %id)
CD557651 testis .a 747 to 1548 1 to 807       807/933
(86 %)
6 diff
(99.4 %id)
DA073808 cerebellum .a 781 to 1315 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA086999 cerebellum .a 782 to 1346 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BX461092 brain, fetal brain .a 789 to 1720 1 to 924       924/970
(95 %)
14 diff
(98.6 %id)
DA088118 cerebellum .a 792 to 1361 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BM552844 amelanotic melanoma, cell line, skin .a 805 to 1767 1 to 966       966/1070
(90 %)
27 diff
(97.5 %id)
BP210486 cerebellum .a 823 to 1402 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AL137941 amygdala .a 833 to 1155 1 to 323       323/323
(100 %)
0 diff
(100 %id)
DA690349   .a 870 to 1430 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CR976993 T-Lymphocytes .a 884 to 1600 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
AA323263 brain, cerebellum .a 887 to 1108 1 to 222       222/222
(100 %)
0 diff
(100 %id)
BQ947594 large cell carcinoma, lung .a 929 to 1776 1 to 849       849/954
(88 %)
17 diff
(98.3 %id)
BX429142 placenta .a 956 to 1686 1 to 731       731/829
(88 %)
21 diff
(97.5 %id)
BX408247 brain, fetal brain .a 961 to 1686 1 to 727       727/831
(87 %)
39 diff
(95.4 %id)
DA522183 brain .a 969 to 1515 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BE780862 eye, retinoblastoma .a 977 to 1684 1 to 713       713/906
(78 %)
15 diff
(98.4 %id)
DB045590 testis .a 977 to 1538 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA503105 brain .a 978 to 1471 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
BU501659 brain, neuroblastoma, cell line .a 983 to 1832 1 to 853       853/910
(93 %)
12 diff
(98.7 %id)
BP267270 thyroid .a 983 to 1563 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA529892 brain .a 995 to 1603 2 to 610   capped   609/609
(100 %)
0 diff
(100 %id)
DA769350 brain .a 996 to 1561 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AW068178 Bone, Hip .a 1006 to 1459 20 to 473       454/473
(95 %)
0 diff
(100 %id)
BX408546 placenta .a 1038 to 1871 1 to 834       834/837
(99 %)
7 diff
(99.2 %id)
BY795680 eye .a 1045 to 1600 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BX450844 brain, fetal brain .a 1116 to 1926 808 to 1       808/893
(90 %)
27 diff
(97.0 %id)
BU859440 ovary, teratocarcinoma, cell line .a 1140 to 1937 1 to 813       811/900
(90 %)
27 diff
(97.0 %id)
TI_1948240781   .a 1213 to 2206 1122 to 121       1002/1308
(76 %)
32 diff
(97.6 %id)
CD107412 brain, Pituitary .a 1224 to 1985 1 to 773       773/890
(86 %)
16 diff
(98.3 %id)
BX450500 brain, fetal brain .a 1234 to 2123 884 to 1       884/885
(99 %)
20 diff
(97.8 %id)
BG822161 adenocarcinoma cell line, colon .a 1256 to 2001 1 to 746       746/746
(100 %)
2 diff
(99.8 %id)
DA089589 cerebellum .a 1258 to 1826 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CR988302 T-Lymphocytes .a 1262 to 2023 1 to 762       762/762
(100 %)
0 diff
(100 %id)
BE336615 adenocarcinoma cell line, ovary .a 1318 to 1975 1 to 658       658/663
(99 %)
2 diff
(99.7 %id)
AU118003 whole embryo, mainly head .a 1319 to 2087 2 to 770   capped   769/792
(97 %)
4 diff
(99.5 %id)
TI_1948240782   .a 1323 to 2206 987 to 115       873/1364
(64 %)
28 diff
(98.0 %id)
AA380581   .a 1330 to 1582 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BE531021 adenocarcinoma, Pancreas .a 1330 to 2168 1 to 826       828/858
(96 %)
28 diff
(96.8 %id)
BE616080 adenocarcinoma, Pancreas .a 1330 to 2168 1 to 826       828/994
(83 %)
34 diff
(96.6 %id)
CB107340 Liver .a 1330 to 1524 1 to 195       195/195
(100 %)
0 diff
(100 %id)
BE740447 adenocarcinoma cell line, ovary .a 1337 to 2121 1 to 786       788/786
(100 %)
13 diff
(98.4 %id)
BQ716398 sympathetic trunk .a 1342 to 2224 1 to 895       895/908
(98 %)
21 diff
(97.7 %id)
BQ717377 sympathetic trunk .a 1342 to 2135 1 to 805       803/939
(85 %)
74 diff
(92.2 %id)
TI_154138458   .a 1384 to 1994 78 to 687       610/610
(100 %)
2 diff
(99.7 %id)
BX450339 brain, fetal brain .a 1404 to 2145 1 to 743       743/743
(100 %)
24 diff
(96.8 %id)
BQ723461 sympathetic trunk .a 1405 to 2143 1 to 741       741/995
(74 %)
14 diff
(98.6 %id)
CD513632 brain, Pituitary .a 1411 to 2272 1 to 865       863/873
(98 %)
9 diff
(99.0 %id)
EB386673 eye, optic nerve .a 1413 to 2046 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BE393119 endometrium, adenocarcinoma cell line, uterus .a 1417 to 2065 1 to 646       646/646
(100 %)
4 diff
(99.4 %id)
DA113805 cerebellum .a 1436 to 1973 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BG119862 adenocarcinoma, cell line, Liver .a 1449 to 2078 1 to 630       630/630
(100 %)
3 diff
(99.6 %id)
BI335731 skin .a 1455 to 1874 1 to 420       420/420
(100 %)
0 diff
(100 %id)
BE710247 head_neck .a 1465 to 2088 627 to 4       624/627
(99 %)
2 diff
(99.7 %id)
BE710269 head_neck .a 1465 to 2088 627 to 4       624/627
(99 %)
2 diff
(99.7 %id)
DA180960 amygdala .a 1472 to 2039 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
EC504099 Prostate .a 1476 to 1594 119 to 1       119/119
(100 %)
0 diff
(100 %id)
BF983680 duodenal adenocarcinoma, cell line, small intestine .a 1496 to 2165 1 to 675       675/1139
(59 %)
13 diff
(98.9 %id)
BU071683 insulinoma, Pancreas .a 1505 to 2086 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
CV572455 cornea, eye .a 1538 to 2154 1 to 617       617/617
(100 %)
0 diff
(100 %id)
TI_1948240498   .a 1596 to 2206 1195 to 591     Submitted on the opposite strand 605/1287
(47 %)
29 diff
(97.8 %id)
CD671375 eye, Iris .a 1611 to 1752 1 to 142       142/142
(100 %)
0 diff
(100 %id)
BG998415 head_neck .a 1660 to 1992 339 to 7       333/341
(97 %)
19 diff
(94.5 %id)
TI_1948241065   .a 1678 to 2206 1119 to 595     Submitted on the opposite strand 528/1316
(40 %)
39 diff
(97.1 %id)
TI_1948240236   .a 1679 to 2206 1122 to 594     Submitted on the opposite strand 529/1286
(41 %)
44 diff
(96.6 %id)
TI_149285441   .a 1681 to 2475 889 to 95   AAA   795/1130
(70 %)
3 diff
(99.8 %id)
AA284169 germinal center B cell .a 1700 to 2036 1 to 347   fully sequenced,   347/347
(100 %)
4 diff
(98.9 %id)
BU680791 lung .a 1781 to 2475 713 to 19   AAA   695/695
(100 %)
0 diff
(100 %id)
TI_151715557   .a 1898 to 2475 704 to 127   AAA   543/842
(64 %)
48 diff
(94.3 %id)
AA284075 germinal center B cell .a 1975 to 2475 501 to 1   fully sequenced,   501/501
(100 %)
2 diff
(99.7 %id)
AA353853   .a 2216 to 2444 1 to 229       229/229
(100 %)
0 diff
(100 %id)
EL949967 eyeball .a 2218 to 2694 87 to 559       473/559
(84 %)
0 diff
(100 %id)
DB322860   .a 2219 to 2805 587 to 1       587/596
(98 %)
3 diff
(99.5 %id)
AA228951   .a 2275 to 2475 216 to 16   AAA   201/201
(100 %)
0 diff
(100 %id)
DB347469 kidney, tumor tissue .a 2275 to 2805 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
CN401051 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2280 to 2475 1 to 196   AAA   196/196
(100 %)
2 diff
(99.0 %id)
AW068088 Bone, Hip .a 2358 to 2770 415 to 3       413/415
(99 %)
0 diff
(100 %id)
FN080120 breast carcinoma .a 2399 to 2493 99 to 8     Submitted on the opposite strand 92/99
(92 %)
0 diff
(100 %id)
AI969184 brain, four pooled pituitary adenomas .a 2427 to 2805 379 to 1       379/379
(100 %)
0 diff
(100 %id)
BF445730 sympathetic trunk .a 2434 to 2806 373 to 1       373/373
(100 %)
0 diff
(100 %id)
AA888616 carcinoid, lung .a 2450 to 2805 367 to 12   AAA   356/356
(100 %)
0 diff
(100 %id)
CB050619 Prostate .a 2476 to 2812 10 to 347   tiling clone, AAA   338/347
(97 %)
0 diff
(100 %id)
BF445729 sympathetic trunk .a 2482 to 2806 325 to 1       325/325
(100 %)
0 diff
(100 %id)
FN053499 breast carcinoma .a 2575 to 2687 1 to 114       114/114
(100 %)
6 diff
(94.8 %id)
BE162178 head_neck .a 2610 to 3091 1 to 482   tiling clone,   482/482
(100 %)
3 diff
(99.4 %id)
FN126322 breast carcinoma .a 2642 to 2747 1 to 105       105/107
(98 %)
4 diff
(96.3 %id)
AI914608 colon .a 2732 to 2806 75 to 1       75/75
(100 %)
1 diff
(98.7 %id)
CN484319 eye .a 2997 to 3595 1 to 599   tiling clone,   599/599
(100 %)
0 diff
(100 %id)
AA733157 heart .a 3130 to 3497 386 to 19   AAA   368/368
(100 %)
0 diff
(100 %id)
BX456275 thymus .a 3388 to 4209 819 to 1   tiling clone,   819/819
(100 %)
18 diff
(97.9 %id)
BG703312 brain, hippocampus .b 1 to 674 1 to 675   tiling clone,   675/679
(99 %)
10 diff
(98.6 %id)
NM_001130107.1   .b 19 to 2530 1 to 2512 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2512/2512
(100 %)
0 diff
(100 %id)
DR762129 embryonic stem .b 21 to 859 1 to 839       839/839
(100 %)
6 diff
(99.3 %id)
BG714188 brain, hypothalamus .b 29 to 789 1 to 764       764/788
(96 %)
22 diff
(97.3 %id)
DB049110 testis .b 29 to 610 2 to 597   capped   596/596
(100 %)
13 diff
(97.9 %id)
BI907261 leukocyte .b 30 to 801 1 to 774       774/774
(100 %)
10 diff
(98.8 %id)
TI_57232677   .b 30 to 801 30 to 803       774/803
(96 %)
8 diff
(99.1 %id)
DA501532 brain .b 32 to 571 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
TI_44165977   .b 33 to 741 129 to 857       649/860
(75 %)
12 diff
(98.7 %id)
TI_44166957   .b 34 to 813 116 to 897       782/898
(87 %)
14 diff
(98.5 %id)
TI_44001170   .b 34 to 793 115 to 873       759/877
(86 %)
4 diff
(99.6 %id)
TI_44342590   .b 34 to 696 108 to 771       664/771
(86 %)
2 diff
(99.8 %id)
DA074637 cerebellum .b 35 to 597 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA088543 cerebellum .b 35 to 371 2 to 338   capped   337/337
(100 %)
2 diff
(99.5 %id)
DA489233 brain .b 35 to 304 2 to 271   capped   270/270
(100 %)
0 diff
(100 %id)
BI667077 brain, hypothalamus .b 36 to 696 1 to 661       661/661
(100 %)
7 diff
(99.0 %id)
BG720536 testis .b 37 to 757 1 to 719       719/726
(99 %)
10 diff
(98.7 %id)
BG720500 testis .b 37 to 762 1 to 724       724/725
(99 %)
14 diff
(98.1 %id)
BI545124 brain, hippocampus .b 37 to 793 1 to 756       756/760
(99 %)
10 diff
(98.7 %id)
TI_57200407   .b 38 to 770 17 to 753       737/753
(97 %)
11 diff
(98.6 %id)
DA483565 brain .b 39 to 771 2 to 734   capped   733/744
(98 %)
7 diff
(99.1 %id)
CR981822 T-Lymphocytes .b 41 to 712 1 to 672       672/675
(99 %)
3 diff
(99.6 %id)
BP209720 cerebellum .b 42 to 624 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BX403707 placenta .b 42 to 1060 1 to 1009       1009/1054
(95 %)
17 diff
(98.4 %id)
BX459974 brain, fetal brain .b 42 to 321 1 to 281       281/286
(98 %)
8 diff
(97.3 %id)
DB472972 hippocampus .b 42 to 505 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
BM542891 embryonal carcinoma, cell line, testis .b 42 to 977 1 to 944       944/1001
(94 %)
22 diff
(97.9 %id)
DA070308 cerebellum .b 43 to 354 2 to 313   capped   312/312
(100 %)
0 diff
(100 %id)
DA350965 substantia nigra .b 43 to 604 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CA396633 eye, RPE/choroid .b 43 to 663 13 to 633       621/633
(98 %)
0 diff
(100 %id)
DA491856 brain .b 43 to 354 2 to 313   capped   312/312
(100 %)
0 diff
(100 %id)
DA521829 brain .b 43 to 600 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA527439 brain .b 43 to 625 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA529297 brain .b 43 to 663 2 to 622   capped   621/621
(100 %)
2 diff
(99.7 %id)
BQ958731 carcinoma, cell line, Prostate .b 43 to 897 1 to 861       861/900
(95 %)
10 diff
(98.9 %id)
DA729293   .b 43 to 769 2 to 735   capped   734/770
(95 %)
14 diff
(98.2 %id)
DA774352 brain .b 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA796390 brain .b 43 to 556 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA802476 brain .b 43 to 582 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA825016 pericardium .b 43 to 473 2 to 432   capped   431/431
(100 %)
0 diff
(100 %id)
DA527539 brain .b 45 to 467 2 to 424   capped   423/423
(100 %)
0 diff
(100 %id)
AA853868 Bone, Hip .b 47 to 355 1 to 302       302/302
(100 %)
18 diff
(94.1 %id)
BX440502 brain, fetal brain .b 51 to 895 1 to 844       844/844
(100 %)
3 diff
(99.7 %id)
DN990148 brain, whole brain .b 51 to 670 1 to 620       620/620
(100 %)
7 diff
(98.9 %id)
BM466786 eye, retinoblastoma .b 53 to 893 1 to 846       846/1039
(81 %)
15 diff
(98.6 %id)
BQ927813 carcinoma, cell line, Prostate .b 53 to 897 1 to 846       846/967
(87 %)
19 diff
(98.1 %id)
BM467738 leiomyosarcoma, uterus .b 55 to 895 1 to 846       846/1129
(74 %)
16 diff
(98.6 %id)
CR999055 T-Lymphocytes .b 55 to 325 1 to 273       273/318
(85 %)
5 diff
(98.5 %id)
BM543116 embryonal carcinoma, cell line, testis .b 56 to 817 1 to 769       769/1003
(76 %)
19 diff
(98.2 %id)
BE263707 lung, small cell carcinoma .b 57 to 762 1 to 702       702/711
(98 %)
14 diff
(98.1 %id)
BM563100 astrocytoma grade IV, cell line, brain .b 57 to 897 1 to 844       844/1098
(76 %)
9 diff
(99.2 %id)
CA389259 eye, RPE/choroid .b 58 to 520 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BU848645 ovary, teratocarcinoma, cell line .b 58 to 940 1 to 889       887/912
(97 %)
12 diff
(98.7 %id)
BQ722897 sympathetic trunk .b 60 to 741 1 to 684       684/946
(72 %)
10 diff
(99.0 %id)
BQ423415 melanotic melanoma, skin .b 61 to 819 11 to 771       761/889
(85 %)
7 diff
(99.3 %id)
BQ717375 sympathetic trunk .b 61 to 897 1 to 839       839/914
(91 %)
16 diff
(98.3 %id)
TI_45208949   .b 61 to 631 85 to 655       571/655
(87 %)
1 diff
(99.9 %id)
CX873164 embryonic stem .b 62 to 866 1 to 805       805/805
(100 %)
3 diff
(99.7 %id)
BQ070405 brain, neuroblastoma, cell line .b 64 to 1060 1 to 1014       1014/1033
(98 %)
11 diff
(99.0 %id)
BQ890190 brain, neuroblastoma, cell line .b 64 to 978 1 to 919       919/929
(98 %)
10 diff
(99.0 %id)
CN292307 embryonic stem cells, cell lines H1, H7, andH9 .b 68 to 765 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
AF527736 medulloblastoma .b 69 to 1480 1 to 1412   tiling clone,   1412/1412
(100 %)
2 diff
(99.9 %id)
BU194141 melanotic melanoma, skin .b 69 to 895 1 to 832       832/921
(90 %)
20 diff
(97.9 %id)
CN292301 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 70 to 716 1 to 647       647/650
(99 %)
3 diff
(99.6 %id)
CN292311 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 70 to 724 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
BX407808 brain, fetal brain .b 70 to 896 1 to 825       825/938
(87 %)
6 diff
(99.4 %id)
BE253740 eye, retinoblastoma .b 73 to 890 1 to 814       814/901
(90 %)
11 diff
(98.8 %id)
CN292309 embryonic stem cells, cell lines H1, H7, andH9 .b 74 to 718 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
DR158126 human embryonic stem cells differentiated toan early endodermal cell type .b 74 to 824 1 to 751       751/751
(100 %)
2 diff
(99.8 %id)
BE780867 eye, retinoblastoma .b 78 to 806 1 to 720       720/897
(80 %)
14 diff
(98.5 %id)
BQ876771 sympathetic trunk .b 89 to 878 39 to 832       794/968
(82 %)
19 diff
(98.1 %id)
DA342880 substantia nigra .b 126 to 707 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BX461374 brain, fetal brain .b 128 to 1124 1 to 990   tiling clone,   990/990
(100 %)
9 diff
(99.1 %id)
DN993145 brain, whole brain .b 149 to 870 1 to 722       722/722
(100 %)
0 diff
(100 %id)
DA152652 amygdala .b 165 to 732 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA054158 cerebellum .b 198 to 735 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA519226 brain .b 222 to 712 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA530091 brain .b 222 to 845 2 to 626   capped   625/627
(99 %)
6 diff
(99.1 %id)
DA599123   .b 222 to 778 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA891572 rectum .b 222 to 773 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_45210807   .b 248 to 1076 80 to 907       828/911
(90 %)
9 diff
(99.1 %id)
BI599803 brain, hypothalamus .b 255 to 1076 1 to 822       822/826
(99 %)
14 diff
(98.4 %id)
DA366256 subthalamic nucleus .b 260 to 813 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA180682 amygdala .b 264 to 842 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA293024 hippocampus .b 264 to 818 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA143792 amygdala .b 283 to 827 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA522516 brain .b 283 to 851 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA530261 brain .b 283 to 897 2 to 617   capped   616/617
(99 %)
3 diff
(99.6 %id)
BU173048 eye, retinoblastoma .b 283 to 1116 1 to 836       836/907
(92 %)
15 diff
(98.4 %id)
DA171618 amygdala .b 294 to 863 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA091457 cerebellum .b 298 to 859 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA348897 substantia nigra .b 302 to 870 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CR618577 Placenta Cot 25-normalized .b 1777 to 2524 1 to 748   tiling clone,   748/748
(100 %)
0 diff
(100 %id)
BX349733 Placenta Cot 25-normalized .b 1777 to 2499 727 to 1       727/727
(100 %)
10 diff
(98.7 %id)
BX349734 Placenta Cot 25-normalized .b 1777 to 2524 1 to 748       748/748
(100 %)
5 diff
(99.4 %id)
BX360886 Placenta Cot 25-normalized .b 1777 to 2524 1 to 750       750/750
(100 %)
4 diff
(99.5 %id)
CO247613 Chondrosarcoma Lung Metastasis cell lines, lung .b 1877 to 2520 40 to 674       635/770
(82 %)
13 diff
(98.4 %id)
BQ019801 Chondrosarcoma, Left Pubic Bone .b 1992 to 2523 552 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 534/535
(99 %)
8 diff
(98.6 %id)
AJ712057 heart .b 2004 to 2493 532 to 41     Submitted on the opposite strand 492/532
(92 %)
0 diff
(100 %id)
AI890626 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2075 to 2524 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AI925587 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2107 to 2523 443 to 27   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 417/418
(99 %)
10 diff
(97.7 %id)
BF059700 pooled germ cell tumors .b 2107 to 2523 417 to 1       417/533
(78 %)
1 diff
(99.9 %id)
AA779883   .b 2108 to 2531 430 to 8   tiling clone,   423/430
(98 %)
3 diff
(99.4 %id)
AA621710   .b 2108 to 2492 384 to 1       384/384
(100 %)
12 diff
(96.9 %id)
AA748819 germinal center B cell .b 2108 to 2524 421 to 9       413/421
(98 %)
4 diff
(99.1 %id)
AA768039 germinal center B cell .b 2108 to 2524 424 to 9       416/424
(98 %)
1 diff
(99.8 %id)
AW340857 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2108 to 2524 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AI915584 ovary, tumor, 5 pooled (see description) .b 2118 to 2524 408 to 2       407/408
(99 %)
5 diff
(98.8 %id)
BE220809 carcinoid, lung .b 2150 to 2524 378 to 4       375/378
(99 %)
0 diff
(100 %id)
T47479 placenta .b 2165 to 2530 1 to 368       368/377
(97 %)
23 diff
(93.9 %id)
AW951345   .b 2181 to 2522 342 to 1     Submitted on the opposite strand 342/349
(97 %)
5 diff
(98.6 %id)
AA598434 lung, lung carcinoma .b 2182 to 2504 328 to 6       323/328
(98 %)
0 diff
(100 %id)
AI698409 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2197 to 2523 326 to 1       326/326
(100 %)
6 diff
(98.2 %id)
AA853867 Bone, Hip .b 2206 to 2505 306 to 9       298/306
(97 %)
0 diff
(100 %id)
AI696373 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2216 to 2530 315 to 1       315/315
(100 %)
2 diff
(99.4 %id)
AW873768 adrenal gland, neuroblastoma .b 2234 to 2524 296 to 6       291/296
(98 %)
0 diff
(100 %id)
BQ921590 leiomyosarcoma, uterus .b 2234 to 2523 1 to 290   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 290/290
(100 %)
0 diff
(100 %id)
BG938658 Bone, Hip .b 2245 to 2537 300 to 8       293/300
(97 %)
0 diff
(100 %id)
AA477672 ovarian tumor, ovary .b 2263 to 2492 1 to 232       232/232
(100 %)
16 diff
(93.2 %id)
T29447 placenta .b 2294 to 2524 236 to 6       231/236
(97 %)
0 diff
(100 %id)
N52851 multiple sclerosis lesions .b 2299 to 2429 132 to 2       131/139
(94 %)
0 diff
(100 %id)
AI634115 pooled germ cell tumors .b 2305 to 2523 219 to 1       219/225
(97 %)
7 diff
(96.9 %id)
AI652911 pooled germ cell tumors .b 2305 to 2523 219 to 1       219/225
(97 %)
4 diff
(98.3 %id)
BF056979 pooled germ cell tumors .b 2305 to 2523 219 to 1       219/225
(97 %)
4 diff
(98.3 %id)
AI648382 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2325 to 2523 200 to 1       200/200
(100 %)
4 diff
(98.0 %id)
AW196565 pooled germ cell tumors .b 2325 to 2524 205 to 5       201/209
(96 %)
0 diff
(100 %id)
AI702023 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2348 to 2524 179 to 3       177/179
(98 %)
0 diff
(100 %id)
BX347347 Placenta Cot 25-normalized .b 2353 to 2524 1 to 169       169/174
(97 %)
4 diff
(97.8 %id)
AI571056 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2354 to 2524 174 to 4       171/174
(98 %)
0 diff
(100 %id)
AK294508 amygdala .c 1 to 2317 6 to 2322 M78I tiling clone,   2322/2322
(100 %)
4 diff
(99.9 %id)
AW802827 uterus .c 1568 to 1971 404 to 1       404/404
(100 %)
4 diff
(99.1 %id)
BF802838 colon_ins .c 1608 to 1945 8 to 342       335/342
(97 %)
1 diff
(99.8 %id)
BM475265 eye, retinoblastoma .c 1883 to 2813 1 to 942   tiling clone,   942/1051
(89 %)
33 diff
(96.9 %id)
BQ320374 colon .c 2154 to 2647 566 to 73   tiling clone,   494/566
(87 %)
0 diff
(100 %id)
NM_182923.3   .d 1 to 2381 1 to 2381 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2381/2381
(100 %)
0 diff
(100 %id)
BJ992457 hepatoblastoma .d 24 to 460 1 to 437   tiling clone,   437/437
(100 %)
0 diff
(100 %id)
L04733 blood .d 45 to 2345 1 to 2299 N4T tiling clone,   2299/2308
(99 %)
8 diff
(99.7 %id)
AB451299   .d 321 to 2030 1 to 1710       1710/1710
(100 %)
3 diff
(99.9 %id)
AB451431   .d 321 to 2027 1 to 1707       1707/1707
(100 %)
3 diff
(99.9 %id)
CN292308 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1454 to 2086 1 to 633       633/633
(100 %)
2 diff
(99.7 %id)
CR608303 T cells (Jurkat cell line) Cot10-normalized .d 1742 to 2376 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BX383632   .d 1742 to 2376 1 to 635   fully sequenced,   635/635
(100 %)
1 diff
(99.9 %id)
BM922657 leukocyte .d 1755 to 2374 1 to 620   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 620/623
(99 %)
2 diff
(99.7 %id)
BF593594 pooled germ cell tumors .d 1786 to 2374 589 to 1       589/590
(99 %)
17 diff
(97.2 %id)
BJ992458 hepatoblastoma .d 1837 to 2342 506 to 1       506/506
(100 %)
1 diff
(99.9 %id)
BM988840 lung, Lung Focal Fibrosis .d 1848 to 2381 552 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 534/534
(100 %)
2 diff
(99.7 %id)
BG007463 placenta_normal .d 1878 to 2314 441 to 8       434/441
(98 %)
0 diff
(100 %id)
BX383631   .d 1928 to 2342 414 to 1   fully sequenced,   414/414
(100 %)
10 diff
(97.6 %id)
NM_005552.4   .e 1 to 2603 1 to 2603 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2603/2603
(100 %)
0 diff
(100 %id)
CX868039 embryonic stem .e 20 to 610 1 to 591   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 591/591
(100 %)
2 diff
(99.7 %id)
BC008881 Uterus, leiomyosarcoma .e 40 to 2596 1 to 2557 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2557/2557
(100 %)
3 diff
(99.9 %id)
AY180164 foreskin .e 54 to 2561 1 to 2508 N4T tiling clone,   2508/2508
(100 %)
3 diff
(99.9 %id)
BM706454 eye, eye anterior segment .e 688 to 901 9 to 222     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 214/222
(96 %)
1 diff
(99.6 %id)
F06922 brain, total brain .e 876 to 1207 1 to 330       330/330
(100 %)
4 diff
(98.8 %id)
AW402153 lymph .e 1170 to 1757 1 to 587     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 587/587
(100 %)
7 diff
(98.9 %id)
BU844652 ovary, teratocarcinoma, cell line .e 1643 to 2519 1 to 881       881/881
(100 %)
12 diff
(98.7 %id)
BU844513 ovary, teratocarcinoma, cell line .e 1644 to 2541 1 to 903       903/904
(99 %)
7 diff
(99.3 %id)
BU553472 ovary, teratocarcinoma, cell line .e 1644 to 2484 1 to 848       848/892
(95 %)
13 diff
(98.6 %id)
TI_149288276   .e 1809 to 2596 885 to 106   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 780/954
(81 %)
20 diff
(98.0 %id)
AI472226 pooled .e 1827 to 2596 782 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 766/766
(100 %)
15 diff
(98.1 %id)
AW370572 breast .e 1901 to 2554 659 to 2       658/662
(99 %)
6 diff
(99.1 %id)
BF679043 Prostate .e 1926 to 2590 1 to 663       663/811
(81 %)
10 diff
(98.8 %id)
BQ183353 Knee, Osteoarthritic Cartilage .e 1940 to 2596 675 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 657/657
(100 %)
5 diff
(99.3 %id)
BM970244 lung .e 1940 to 2596 675 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
BU633386 cell lines, Chondrosarcoma .e 1940 to 2596 675 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
AW370619 breast .e 1946 to 2591 644 to 2       643/644
(99 %)
5 diff
(99.3 %id)
AW574693 lymph .e 2019 to 2596 595 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
CX867956 embryonic stem .e 2082 to 2596 543 to 29   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 515/515
(100 %)
3 diff
(99.5 %id)
BM673280 eye, eye anterior segment .e 2112 to 2596 504 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 486/486
(100 %)
2 diff
(99.6 %id)
F03186 brain, total brain .e 2264 to 2596 333 to 1       333/333
(100 %)
1 diff
(99.7 %id)
CR607419 fetal brain .f 1 to 2416 1 to 2416 exact tiling clone,   2416/2416
(100 %)
0 diff
(100 %id)
CR613465 fetal brain .f 471 to 2430 1 to 1960       1960/1960
(100 %)
0 diff
(100 %id)
CR619184 fetal brain .f 524 to 2426 1 to 1903       1903/1903
(100 %)
0 diff
(100 %id)
BI670312 brain, hypothalamus .f 1225 to 2007 1 to 784       784/785
(99 %)
9 diff
(98.9 %id)
BI667985 brain, hypothalamus .f 1225 to 2004 1 to 777       777/782
(99 %)
7 diff
(99.2 %id)
TI_44345788   .f 1228 to 2007 93 to 873       781/874
(89 %)
5 diff
(99.5 %id)
TI_44346394   .f 1228 to 2004 124 to 897       774/902
(85 %)
3 diff
(99.7 %id)
CK001684 brain/CNS, Bulk tissue from Human Spinal cord .f 1362 to 2033 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
BX461091 brain, fetal brain .f 1367 to 2427 1052 to 5       1048/1052
(99 %)
22 diff
(98.0 %id)
CB129250 Liver .f 1374 to 1969 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BX461373 brain, fetal brain .f 1376 to 2416 1040 to 1       1040/1040
(100 %)
9 diff
(99.2 %id)
BM710687 eye, fetal eyes .f 1401 to 1908 1 to 508     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 508/508
(100 %)
1 diff
(99.9 %id)
CA306755 Alveolar Macrophage, lung .f 1450 to 2124 693 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 675/675
(100 %)
0 diff
(100 %id)
BX420903 brain, fetal brain .f 1456 to 2389 934 to 1       934/934
(100 %)
9 diff
(99.1 %id)
BF852895 lung_normal .f 1466 to 2041 592 to 17     Submitted on the opposite strand 576/592
(97 %)
0 diff
(100 %id)
BF853286 lung_normal .f 1469 to 2028 1 to 561       561/561
(100 %)
4 diff
(99.3 %id)
BQ334197 marrow .f 1476 to 1950 480 to 5       476/480
(99 %)
4 diff
(99.2 %id)
BU857356 adenocarcinoma, cell line, breast .f 1494 to 2346 1 to 861       861/893
(96 %)
15 diff
(98.4 %id)
AW749735 breast .f 1495 to 2040 556 to 10       547/556
(98 %)
1 diff
(99.9 %id)
BU856885 adenocarcinoma, cell line, breast .f 1505 to 2346 11 to 853       843/927
(90 %)
6 diff
(99.4 %id)
BQ330608 lung_tumor .f 1508 to 1997 487 to 1       487/587
(82 %)
14 diff
(97.7 %id)
AV725909 hypothalamus .f 1512 to 2138 1 to 623       623/623
(100 %)
20 diff
(96.8 %id)
AY180163 superior frontal cortex .f 1522 to 2125 1 to 604   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 604/606
(99 %)
1 diff
(99.9 %id)
AY244715   .f 1522 to 2419 1 to 898       898/898
(100 %)
2 diff
(99.8 %id)
BM991797 Bone, Subchondral Bone .f 1523 to 2125 623 to 21       603/623
(96 %)
0 diff
(100 %id)
DB575700 hypothalamus .f 1550 to 2043 1 to 494     Submitted on the opposite strand 494/494
(100 %)
1 diff
(99.8 %id)
AI422004 brain, glioblastoma (pooled) .f 1552 to 2125 574 to 1       574/574
(100 %)
0 diff
(100 %id)
AW138863   .f 1558 to 2124 584 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 567/567
(100 %)
2 diff
(99.7 %id)
BX440501 brain, fetal brain .f 1571 to 2419 855 to 1       855/855
(100 %)
49 diff
(94.3 %id)
BX407807 brain, fetal brain .f 1571 to 2400 830 to 1       830/902
(92 %)
7 diff
(99.3 %id)
DB568205 hypothalamus .f 1573 to 2043 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
EL955540 eyeball .f 1597 to 2034 1 to 439       439/448
(97 %)
5 diff
(98.9 %id)
DA176507 amygdala .f 1598 to 2146 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BQ720142 sympathetic trunk .f 1616 to 2455 1 to 845   AAA   845/936
(90 %)
16 diff
(98.3 %id)
EL949539 eyeball .f 1655 to 1893 1 to 240       240/240
(100 %)
6 diff
(97.5 %id)
BM695952 eye, human retina .f 1658 to 2270 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
AI424093 brain, glioblastoma (pooled) .f 1671 to 2124 449 to 1       449/493
(91 %)
17 diff
(96.6 %id)
AI097557 brain, glioblastoma (pooled) .f 1678 to 2125 448 to 1       448/449
(99 %)
7 diff
(98.5 %id)
H40608 brain .f 1680 to 1742 1 to 63       63/63
(100 %)
0 diff
(100 %id)
BI488938 brain .f 1690 to 2124 1 to 435   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 435/435
(100 %)
0 diff
(100 %id)
TI_45379884   .f 1690 to 2124 70 to 504   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 435/504
(86 %)
0 diff
(100 %id)
BF885697 testis_normal .f 1697 to 1895 214 to 16     Submitted on the opposite strand 199/225
(88 %)
1 diff
(99.6 %id)
TI_153949520   .f 1730 to 2179 81 to 535       455/547
(83 %)
10 diff
(98.2 %id)
H27867 brain .f 1765 to 2115 363 to 10       354/366
(96 %)
5 diff
(98.7 %id)
CK005266 brain/CNS, Human Brain - Frontal Cortex .f 1784 to 2436 1 to 654       654/665
(98 %)
9 diff
(98.7 %id)
H27868 brain .f 1802 to 2112 310 to 1       310/310
(100 %)
3 diff
(99.1 %id)
BU736290 eye, fetal eyes .f 2127 to 2454 346 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 328/328
(100 %)
1 diff
(99.7 %id)
BM463469 embryonal carcinoma, cell line, testis .g 1 to 963 1 to 968   tiling clone,   968/1040
(93 %)
37 diff
(96.5 %id)
BG678239 skin, squamous cell carcinoma .g 225 to 953 1 to 729   tiling clone,   729/766
(95 %)
9 diff
(98.9 %id)
AY180165   .g 428 to 1403 1 to 974   tiling clone,   977/974
(100 %)
3 diff
(99.7 %id)
AK296465 thalamus .g 1297 to 2839 1 to 1555   tiling clone,   1555/1555
(100 %)
7 diff
(99.6 %id)
DC343548 thalamus .g 1297 to 1853 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
DB245811 uterus, tumor tissue .g 1342 to 1835 2 to 496   capped   495/495
(100 %)
1 diff
(99.8 %id)
DA733280   .g 1356 to 1917 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
CB153641 brain .g 1549 to 2125 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
AA350020 brain .g 1971 to 2246 1 to 289   tiling clone,   289/292
(98 %)
8 diff
(97.3 %id)
BI770955 pooled lung and spleen .g 2128 to 3070 8 to 963   tiling clone,   956/963
(99 %)
40 diff
(95.9 %id)
TI_57183044   .g 2128 to 3070 42 to 997       956/997
(95 %)
40 diff
(96.0 %id)
CN370414 embryonic stem cells, cell lines H1, H7, andH9 .g 2167 to 2678 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
DA046237 bladder .g 2180 to 2720 2 to 542   tiling clone, capped   541/541
(100 %)
2 diff
(99.7 %id)
DA926130 small intestine .g 2272 to 2843 2 to 573   tiling clone, capped   572/574
(99 %)
2 diff
(99.7 %id)
BG015141 placenta_normal .g 2380 to 2797 1 to 420       420/423
(99 %)
11 diff
(97.4 %id)
BU182714 melanotic melanoma, skin .h 1 to 696 48 to 752   tiling clone,   703/873
(80 %)
15 diff
(98.3 %id)
BG255102 adenocarcinoma, cell line, Prostate .h 503 to 1238 1 to 735   tiling clone,   735/753
(97 %)
11 diff
(98.6 %id)
AW867816 stomach_normal .i 1 to 563 11 to 571   tiling clone,   561/571
(98 %)
0 diff
(100 %id)
BM699985 eye, lens .i 536 to 1164 1 to 629   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 629/629
(100 %)
0 diff
(100 %id)
BE314858 brain, neuroblastoma .i 924 to 1578 27 to 677   tiling clone,   653/677
(96 %)
5 diff
(99.3 %id)
BF311534 brain, neuroblastoma .i 933 to 1586 1 to 654       656/893
(73 %)
8 diff
(99.2 %id)
BP210747 cerebellum .i 1069 to 1650 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM669945 eye, lens .i 1177 to 1890 732 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 714/714
(100 %)
0 diff
(100 %id)
CF265004 Brain glioblastoma .j 1 to 843 1 to 851 D7I H8I P9L A10R V11W ... tiling clone,   848/856
(99 %)
17 diff
(98.1 %id)
T09255   .j 192 to 406 1 to 215       215/215
(100 %)
1 diff
(99.6 %id)
BM794298 Ascites, stomach .j 237 to 889 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BE543939 cervical carcinoma cell line, cervix .j 380 to 997 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BM793384 Ascites, stomach .j 553 to 872 1 to 320       320/320
(100 %)
12 diff
(96.3 %id)
AI377204 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 602 to 1079 478 to 1   tiling clone,   478/478
(100 %)
0 diff
(100 %id)
T09254   .j 1008 to 1409 405 to 1   tiling clone,   405/405
(100 %)
4 diff
(99.1 %id)
BQ963020 epithelioid carcinoma cell line, Pancreas .k 1 to 930 1 to 930 S261T tiling clone,   930/931
(99 %)
19 diff
(98.0 %id)
CA406424 adipose .k 924 to 1377 454 to 1   tiling clone, Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
BE174202 head_neck .k 1100 to 1277 8 to 186       179/190
(94 %)
6 diff
(96.9 %id)
BQ787824 insulinoma, Pancreas .l 1 to 500 1 to 499       499/499
(100 %)
7 diff
(98.6 %id)
BU947818 insulinoma, Pancreas .l 1 to 596 1 to 596   tiling clone,   596/596
(100 %)
5 diff
(99.2 %id)
CN292305 embryonic stem cells, cell lines H1, H7, andH9 .l 287 to 916 1 to 632   tiling clone,   632/632
(100 %)
2 diff
(99.7 %id)
CD673439 eye, lens .l 634 to 1195 1 to 562   tiling clone,   562/562
(100 %)
1 diff
(99.9 %id)
BU947551 insulinoma, Pancreas .l 1832 to 2472 643 to 2   tiling clone,   642/643
(99 %)
0 diff
(100 %id)
BQ787648 insulinoma, Pancreas .l 1851 to 2438 589 to 1       589/589
(100 %)
4 diff
(99.4 %id)
DR156018 human embryonic stem cells differentiated toan early endodermal cell type .m 1 to 766 1 to 766 exact tiling clone,   766/766
(100 %)
2 diff
(99.8 %id)
TI_154102644   .m 164 to 825 708 to 45       664/867
(76 %)
7 diff
(99.2 %id)
AY180166   .m 181 to 864 1 to 684       684/685
(99 %)
19 diff
(97.3 %id)
DB465068.
matches multiple genes
hippocampus .m 426 to 861 1 to 435     also hits gene notabo 435/435
(100 %)
6 diff
(98.7 %id)
DB471871.
matches multiple genes
hippocampus .m 426 to 925 1 to 500   tiling clone, also hits gene notabo 500/500
(100 %)
2 diff
(99.6 %id)
BE793750 lung, small cell carcinoma .n 1 to 685 1 to 685 L2W F15L G16V S17L V18* tiling clone,   685/971
(70 %)
10 diff
(99.0 %id)
BG519533 brain, neuroblastoma .o 1 to 788 6 to 802 R4E A5L L6W E7K I8S ... tiling clone,   800/802
(99 %)
29 diff
(96.4 %id)
AI016892 pooled .p-u 1 to 381 3 to 383     Submitted on the opposite strand 383/383
(100 %)
3 diff
(99.3 %id)
AK092888 Spleen .p-u 1 to 2840 2 to 2841 exact tiling clone, available from FLJ,   2841/2841
(100 %)
3 diff
(99.9 %id)
AX747791   .p-u 1 to 2840 2 to 2841 exact     2841/2841
(100 %)
3 diff
(99.9 %id)
AA773310 lung, lung carcinoma .p-u 1 to 369 2 to 370   tiling clone, Submitted on the opposite strand 370/370
(100 %)
2 diff
(99.5 %id)
DA934791 Spleen .p-u 1 to 461 2 to 464   capped   463/463
(100 %)
4 diff
(99.2 %id)
BF753163 breast_normal .p-u 2 to 412 1 to 411       411/435
(94 %)
15 diff
(96.6 %id)
AA666395   .p-u 3 to 424 1 to 422     Submitted on the opposite strand 422/422
(100 %)
2 diff
(99.6 %id)
DR005649 Prostate .p-u 5 to 514 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
DA125684 cerebellum .p-u 42 to 626 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
BQ314528 breast_normal .p-u 92 to 412 361 to 42       320/361
(88 %)
0 diff
(100 %id)
BX104759 pooled .p-u 143 to 426 286 to 2     Submitted on the opposite strand 285/286
(99 %)
0 diff
(100 %id)
DA793921 brain .p-u 297 to 842 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DR003021 fetal brain .p-u 331 to 484 1 to 154       154/154
(100 %)
3 diff
(98.1 %id)
CX787973 human embryonic stem cells .p-u 469 to 1264 1 to 796 exact     796/796
(100 %)
0 diff
(100 %id)
CX787740 human embryonic stem cells .p-u 469 to 1304 1 to 836 exact     836/836
(100 %)
2 diff
(99.8 %id)
DW419284 Liver .p-u 714 to 1000 17 to 303       287/303
(94 %)
0 diff
(100 %id)
DA228384 brain .p-u 715 to 1273 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA083529 cerebellum .p-u 750 to 1248 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
DW411357 Liver .p-u 852 to 1162 17 to 327   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 311/329
(94 %)
4 diff
(98.8 %id)
DW462325 Liver .p-u 852 to 1167 17 to 332       316/369
(85 %)
6 diff
(98.4 %id)
DA263760 caudate nucleus .p-u 869 to 1413 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
BI015156 lung_tumor .p-u 878 to 1209 24 to 349       326/349
(93 %)
0 diff
(100 %id)
BQ346918 nervous_tumor .p-u 1084 to 1303 1 to 220       220/245
(89 %)
9 diff
(96.4 %id)
BQ346913 nervous_tumor .p-u 1089 to 1303 24 to 238       215/263
(81 %)
7 diff
(97.4 %id)
BQ346916 nervous_tumor .p-u 1089 to 1303 25 to 239       215/264
(81 %)
4 diff
(98.5 %id)
BQ346874 nervous_tumor .p-u 1098 to 1299 7 to 217       211/223
(94 %)
12 diff
(94.7 %id)
AW836567 leiomios .p-u 1106 to 1723 1 to 618       618/618
(100 %)
13 diff
(97.9 %id)
AW836540 leiomios .p-u 1109 to 1800 1 to 684       684/684
(100 %)
22 diff
(96.8 %id)
DB139326 thymus .p-u 1115 to 1655 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB177008 kidney, tumor tissue .p-u 1146 to 1670 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
CB156497 brain .p-u 1170 to 1843 1 to 674       674/674
(100 %)
0 diff
(100 %id)
BQ360097 head_normal .p-u 1196 to 1597 408 to 2       407/408
(99 %)
0 diff
(100 %id)
DA228915 brain .p-u 1253 to 1834 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BE173769 head_neck .p-u 1291 to 1446 159 to 7     Submitted on the opposite strand 153/162
(94 %)
9 diff
(94.5 %id)
DA400257 thalamus .p-u 1297 to 1842 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
AW836665 leiomios .p-u 1332 to 1884 557 to 7       551/557
(98 %)
0 diff
(100 %id)
R56336 whole brain .p-u 1753 to 2127 1 to 379       379/499
(75 %)
12 diff
(97.6 %id)
AI656794 pooled germ cell tumors .p-u 1808 to 2217 423 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
R25832 whole brain .p-u 1837 to 2187 1 to 353       353/527
(66 %)
8 diff
(98.5 %id)
R61106 whole brain .p-u 1847 to 2350 1 to 514       514/514
(100 %)
21 diff
(96.0 %id)
AK054874 cerebellum .p-u 1908 to 3170 1 to 1263   tiling clone, available from FLJ,   1263/1263
(100 %)
2 diff
(99.9 %id)
DA057084 cerebellum .p-u 1909 to 2513 2 to 606   capped   605/605
(100 %)
1 diff
(99.9 %id)
BM907997 brain, medulla .p-u 2039 to 2929 1 to 903       903/1094
(82 %)
31 diff
(97.2 %id)
DB286400 uterus .p-u 2228 to 2782 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB306767 caudate nucleus .p-u 2299 to 2840 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DB251969 uterus .p-u 2321 to 2774 2 to 455   capped   454/454
(100 %)
1 diff
(99.8 %id)
AA508740 Prostate .p-u 2348 to 2663 1 to 316       316/316
(100 %)
3 diff
(99.1 %id)
AA345614 gall bladder .p-u 2448 to 2721 1 to 276       276/278
(99 %)
5 diff
(98.3 %id)
AW963252   .p-u 2449 to 3161 1 to 720       720/721
(99 %)
24 diff
(96.7 %id)
DB296666 cerebellum .p-u 2623 to 3170 548 to 1       548/548
(100 %)
1 diff
(99.9 %id)
R46830 whole brain .p-u 2823 to 3171 367 to 9   tiling clone,   359/426
(84 %)
0 diff
(100 %id)
CB136383 Liver .q 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
2 diff
(99.7 %id)
NM_032374.3   .q 1 to 1233 1 to 1233 exact RefSeq, AAA   1233/1233
(100 %)
0 diff
(100 %id)
BP368962 testis .q 2 to 566 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BU181154 large cell carcinoma, lung .q 12 to 787 12 to 798   AAA   789/901
(87 %)
27 diff
(97.1 %id)
CD050178 embryonic trophoblasts, made from WA01 stemcells .q 14 to 853 20 to 858       839/862
(97 %)
6 diff
(99.4 %id)
BG679885 skin, squamous cell carcinoma .q 14 to 795 1 to 780       780/781
(99 %)
8 diff
(99.0 %id)
AK223092   .q 25 to 871 1 to 847   AAA   847/847
(100 %)
2 diff
(99.8 %id)
AK223103   .q 25 to 871 1 to 847   AAA   847/847
(100 %)
2 diff
(99.8 %id)
BG335102 choriocarcinoma, placenta .q 27 to 760 1 to 728       728/976
(74 %)
24 diff
(97.6 %id)
BC007412 Ovary, adenocarcinoma .q 33 to 2507 1 to 2477   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2477/2477
(100 %)
2 diff
(100.0 %id)
BE272446 adenocarcinoma cell line, ovary .q 33 to 680 24 to 670       647/671
(96 %)
3 diff
(99.6 %id)
CD644096 Embryonic Stem cells .q 35 to 814 12 to 781       770/816
(94 %)
13 diff
(98.5 %id)
BG752872 eye, normal pigmented retinal epithelium .q 38 to 837 1 to 796       796/797
(99 %)
8 diff
(99.0 %id)
BG752974 eye, normal pigmented retinal epithelium .q 38 to 878 1 to 842       838/842
(99 %)
14 diff
(98.4 %id)
BG819791 anaplastic oligodendroglioma with 1p/19qloss, brain .q 39 to 744 1 to 704       704/705
(99 %)
4 diff
(99.5 %id)
BM473134 duodenal adenocarcinoma, cell line, small intestine .q 45 to 863 1 to 820       820/823
(99 %)
3 diff
(99.7 %id)
AA282368 germinal center B cell .q 49 to 566 1 to 513       513/513
(100 %)
9 diff
(98.3 %id)
BE880036 large cell carcinoma, undifferentiated, lung .q 49 to 601 1 to 549       549/551
(99 %)
6 diff
(99.0 %id)
BE514601 adenocarcinoma cell line, ovary .q 52 to 744 1 to 685       685/695
(98 %)
13 diff
(98.2 %id)
BE741263 adenocarcinoma cell line, ovary .q 52 to 887 1 to 835       835/909
(91 %)
29 diff
(96.9 %id)
BE899464 adenocarcinoma cell line, ovary .q 52 to 832 1 to 770       770/907
(84 %)
16 diff
(98.3 %id)
BE742424 adenocarcinoma cell line, ovary .q 53 to 886 1 to 831       831/832
(99 %)
17 diff
(98.0 %id)
BE614868 adenocarcinoma, Pancreas .q 61 to 912 1 to 851       851/1092
(77 %)
36 diff
(96.8 %id)
CN261582 embryonic stem cells, cell lines H1, H7, andH9 .q 71 to 562 1 to 492       492/492
(100 %)
0 diff
(100 %id)
AW182877 cervix, tumor .q 83 to 571 1 to 489     Submitted on the opposite strand 489/489
(100 %)
1 diff
(99.8 %id)
TI_154123601   .q 108 to 863 856 to 109   AAA   748/914
(81 %)
12 diff
(98.7 %id)
CA419056 Chondrosarcoma Grade II, Left Pelvis .q 196 to 863 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
CB853339 Human Lung Epithelial cells, lung .q 206 to 863 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
BU633274 cell lines, Chondrosarcoma .q 210 to 863 671 to 19   AAA   653/695
(93 %)
3 diff
(99.6 %id)
AW963964   .q 234 to 863 1 to 630   AAA   630/630
(100 %)
1 diff
(99.9 %id)
CA430098 cell lines, Chondrosarcoma .q 262 to 863 619 to 19   AAA   601/601
(100 %)
1 diff
(99.9 %id)
AI338689 lung .q 294 to 778 494 to 10       485/503
(96 %)
0 diff
(100 %id)
BM712571 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 295 to 836 1 to 542   fully sequenced,   542/542
(100 %)
0 diff
(100 %id)
BP233146 muscle .q 310 to 818 1 to 509       509/512
(99 %)
3 diff
(99.5 %id)
BQ028142 mixed .q 314 to 863 567 to 19   AAA   549/549
(100 %)
4 diff
(99.3 %id)
BM723570 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 341 to 863 1 to 523   AAA   523/523
(100 %)
0 diff
(100 %id)
TI_151727556   .q 341 to 863 608 to 86   AAA   523/687
(76 %)
1 diff
(99.9 %id)
BM825991 Ascites, stomach .q 344 to 570 1 to 228       228/228
(100 %)
6 diff
(97.4 %id)
AA279644 germinal center B cell .q 346 to 620 1 to 274   fully sequenced,   274/274
(100 %)
1 diff
(99.7 %id)
BM676315 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 395 to 863 487 to 19   fully sequenced, AAA   469/469
(100 %)
2 diff
(99.6 %id)
AI198695   .q 401 to 863 470 to 8       463/470
(98 %)
0 diff
(100 %id)
AA700826 liver and spleen .q 404 to 863 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
BQ013248 placenta .q 412 to 863 470 to 19   AAA   452/452
(100 %)
1 diff
(99.8 %id)
AI949273 2 pooled tumors (clear cell type), Kidney .q 422 to 863 465 to 24   AAA   442/447
(98 %)
5 diff
(98.9 %id)
BG191558   .q 430 to 625 48 to 241       194/241
(80 %)
1 diff
(99.6 %id)
AA862357 2 pooled tumors (clear cell type), Kidney .q 433 to 862 432 to 4       429/432
(99 %)
1 diff
(99.8 %id)
BE674578 carcinoid, lung .q 448 to 863 433 to 18   AAA   416/416
(100 %)
4 diff
(99.1 %id)
AA343162 Spleen .q 460 to 594 1 to 135       135/146
(92 %)
1 diff
(99.4 %id)
AA723189 heart .q 460 to 863 406 to 3       404/406
(99 %)
0 diff
(100 %id)
AI335092 2 pooled tumors (clear cell type), Kidney .q 471 to 863 407 to 15   AAA   393/393
(100 %)
1 diff
(99.8 %id)
AI620500 Prostate .q 471 to 863 406 to 13   AAA   394/394
(100 %)
2 diff
(99.5 %id)
BE464902 carcinoid, lung .q 475 to 863 402 to 14   AAA   389/389
(100 %)
7 diff
(98.3 %id)
AI189794 placenta .q 476 to 863 404 to 17   AAA   388/388
(100 %)
5 diff
(98.8 %id)
AI809353 pooled .q 479 to 863 402 to 18       385/402
(95 %)
0 diff
(100 %id)
AI689963 carcinoid, lung .q 481 to 864 387 to 4       384/387
(99 %)
0 diff
(100 %id)
AW956539   .q 482 to 952 1 to 471       471/473
(99 %)
2 diff
(99.6 %id)
AI216368 pooled .q 482 to 863 386 to 5       382/386
(98 %)
0 diff
(100 %id)
AI581305 lung .q 485 to 863 400 to 22   AAA   379/379
(100 %)
5 diff
(98.7 %id)
AW002229 thymus, pooled .q 488 to 863 378 to 4       375/378
(99 %)
3 diff
(99.3 %id)
BE326483 carcinoid, lung .q 492 to 863 379 to 8       372/379
(98 %)
0 diff
(100 %id)
AI268857 carcinoid, lung .q 504 to 860 359 to 3       357/369
(96 %)
0 diff
(100 %id)
AA918077 2 pooled tumors (clear cell type), Kidney .q 515 to 863 357 to 10       348/357
(97 %)
0 diff
(100 %id)
BQ018340 lung, Metastatic Chondrosarcoma .q 518 to 863 364 to 19   AAA   346/350
(98 %)
3 diff
(99.2 %id)
BG188949   .q 525 to 831 307 to 1     Submitted on the opposite strand 307/307
(100 %)
4 diff
(98.7 %id)
BM791560 Ascites, stomach .q 525 to 1171 1 to 647       647/647
(100 %)
0 diff
(100 %id)
AA699747 liver and spleen .q 528 to 863 345 to 11   AAA   335/335
(100 %)
10 diff
(97.1 %id)
AI084719 senescent fibroblast .q 528 to 863 338 to 3       336/338
(99 %)
0 diff
(100 %id)
AV705905 adrenal gland .q 530 to 931 1 to 403       403/619
(65 %)
6 diff
(99.1 %id)
BM690164 eye, human retina .q 530 to 939 3 to 412   fully sequenced, AAA   410/412
(99 %)
5 diff
(98.8 %id)
AA765982 germinal center B cell .q 560 to 836 278 to 1       278/278
(100 %)
4 diff
(98.6 %id)
AA768017 germinal center B cell .q 560 to 863 322 to 19   AAA   304/304
(100 %)
0 diff
(100 %id)
F20342 pectoral muscle (after mastectomy) .q 562 to 863 1 to 304       304/305
(99 %)
6 diff
(98.1 %id)
AA297179 colon .q 569 to 738 1 to 170       170/170
(100 %)
0 diff
(100 %id)
AW955447   .q 570 to 863 1 to 294   AAA   294/294
(100 %)
0 diff
(100 %id)
AW450322   .q 571 to 863 310 to 18   AAA   293/303
(96 %)
0 diff
(100 %id)
CA443899 Fibrosarcoma .q 571 to 1233 674 to 12   AAA   663/663
(100 %)
0 diff
(100 %id)
F17377 pectoral muscle (after mastectomy) .q 584 to 863 1 to 281       281/282
(99 %)
8 diff
(97.2 %id)
AA279848 germinal center B cell .q 590 to 842 253 to 1   fully sequenced,   253/253
(100 %)
3 diff
(98.9 %id)
AA601126 synovial sarcoma .q 598 to 863 273 to 9       265/279
(94 %)
0 diff
(100 %id)
AA928823 pooled .q 687 to 863 176 to 1       176/176
(100 %)
1 diff
(99.5 %id)
BI964187 Islets of Langerhans, Pancreas .q 704 to 863 1 to 160       160/191
(83 %)
1 diff
(99.5 %id)
CK903803 Islets of Langerhans, Pancreas .q 704 to 863 1 to 160       160/160
(100 %)
0 diff
(100 %id)
C21359   .q 710 to 862 1 to 154       154/157
(98 %)
2 diff
(98.8 %id)
AA594412 colon, colon tumor RER+ .q 740 to 863 158 to 35   AAA   124/124
(100 %)
0 diff
(100 %id)
AA583591 larynx .q 740 to 863 130 to 8       123/130
(94 %)
0 diff
(100 %id)
DR978218 brain .q 745 to 863 1 to 119     Submitted on the opposite strand 119/129
(92 %)
3 diff
(97.7 %id)
AI138918 placenta .q 762 to 1227 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI371804   .q 763 to 1229 485 to 7       479/485
(98 %)
0 diff
(100 %id)
AA741020 germinal center B cell .q 765 to 1226 476 to 15   AAA   462/462
(100 %)
1 diff
(99.8 %id)
AI268564 carcinoid, lung .q 813 to 1225 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AW276933 ovary, papillary serous ovarian metastasis .q 813 to 1207 34 to 428     Submitted on the opposite strand 395/428
(92 %)
0 diff
(100 %id)
CR740360   .q 827 to 1225 413 to 15   AAA   399/399
(100 %)
1 diff
(99.8 %id)
F25348 pectoral muscle (after mastectomy) .q 832 to 1112 1 to 281       281/281
(100 %)
6 diff
(97.9 %id)
AI273675 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 833 to 1228 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BG170524 hypernephroma, cell line, Kidney .q 834 to 1225 44 to 433   AAA   390/433
(90 %)
0 diff
(100 %id)
BX100650 whole brain .q 837 to 1225 403 to 15   AAA   389/390
(99 %)
1 diff
(99.8 %id)
AA321595   .q 845 to 1161 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
AW961606   .q 846 to 1226 1 to 381   AAA   381/381
(100 %)
0 diff
(100 %id)
BU535793 mixed (pool of 40 RNAs) .q 859 to 1235 1 to 377       377/883
(42 %)
2 diff
(99.8 %id)
R38509 whole brain .q 891 to 1226 354 to 12   AAA   343/384
(89 %)
9 diff
(97.7 %id)
BM662212 eye, human retina .q 909 to 1233 336 to 12   fully sequenced, AAA   325/325
(100 %)
0 diff
(100 %id)
AA227888 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 1382 to 1803 422 to 1       422/422
(100 %)
0 diff
(100 %id)
BM792097 Ascites, stomach .r 1 to 652 1 to 652 D60Y E173D E187K tiling clone,   652/652
(100 %)
3 diff
(99.6 %id)
CA308208 Alveolar Macrophage, lung .r 426 to 1131 722 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 704/704
(100 %)
3 diff
(99.6 %id)
BM676141 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .r 569 to 1127 577 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 559/567
(98 %)
2 diff
(99.7 %id)
BM916709 amelanotic melanoma, cell line, skin .s 1 to 851 1 to 873 exact tiling clone,   873/1181
(73 %)
49 diff
(95.9 %id)
AW901232 nervous_normal .s 184 to 482 330 to 18       313/330
(94 %)
12 diff
(96.4 %id)
BF766455 colon_est .s 348 to 683 366 to 31   tiling clone, Submitted on the opposite strand 336/366
(91 %)
4 diff
(99.0 %id)
BX408460 brain, fetal brain .t 1 to 856 855 to 1 S2I C3S K11Q E14V T15S ... tiling clone,   855/855
(100 %)
14 diff
(98.4 %id)
BM796200 Ascites, stomach .t 119 to 653 1 to 535   tiling clone,   535/535
(100 %)
1 diff
(99.9 %id)
H21003 brain .t 317 to 579 1 to 263   fully sequenced,   263/263
(100 %)
1 diff
(99.7 %id)
H20962 brain .t 548 to 845 298 to 1   tiling clone, fully sequenced,   298/298
(100 %)
2 diff
(99.4 %id)
CB993873 placenta, pre-eclamptic placenta .u 1 to 783 28 to 817 exact tiling clone,   790/817
(96 %)
14 diff
(98.3 %id)
N42002 placenta .u 15 to 504 1 to 417   fully sequenced,   412/412
(100 %)
19 diff
(95.4 %id)
N30280 placenta .u 485 to 926 460 to 20   tiling clone, fully sequenced, AAA   441/441
(100 %)
2 diff
(99.6 %id)
BM856441 stomach .va-u 1 to 502 1 to 502   tiling clone,   502/502
(100 %)
4 diff
(99.3 %id)
AW662411 colon, moderately-differentiated adenocarcinoma .va-u 150 to 601 452 to 1   tiling clone,   452/452
(100 %)
3 diff
(99.4 %id)
BP213149 cerebrum .vb 1 to 578 1 to 578 G3X S142I tiling clone,   578/578
(100 %)
3 diff
(99.5 %id)
CB121691 brain .vb 119 to 615 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
BE262290 brain, neuroblastoma .vb 306 to 935 1 to 630   tiling clone,   630/630
(100 %)
14 diff
(97.8 %id)
CN401053 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vb 477 to 884 1 to 408   tiling clone,   408/408
(100 %)
2 diff
(99.6 %id)
BG011595 placenta_normal .vc-u 1 to 468 24 to 486   tiling clone,   463/486
(95 %)
0 diff
(100 %id)
BG011605 placenta_normal .vc-u 1 to 468 30 to 496   tiling clone,   467/496
(94 %)
0 diff
(100 %id)
BF887272 testis_normal .vd-u 1 to 401 5 to 406   tiling clone,   406/406
(100 %)
3 diff
(99.3 %id)
DA494832 brain .vd-u 1 to 527 2 to 529   tiling clone, capped   528/528
(100 %)
3 diff
(99.5 %id)
BX499969 Liver .vd-u 446 to 634 189 to 1   AAA Submitted on the opposite strand 189/192
(98 %)
0 diff
(100 %id)
AW139798   .vd-u 446 to 880 1 to 435   tiling clone, Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
BF445090 carcinoid, lung .vd-u 460 to 916 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
AI299498 carcinoid, lung .vd-u 464 to 912 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
AI458993 carcinoid, lung .vd-u 464 to 955 1 to 492     Submitted on the opposite strand 492/492
(100 %)
1 diff
(99.8 %id)
BE549619 carcinoid, lung .vd-u 464 to 1003 1 to 540     Submitted on the opposite strand 540/540
(100 %)
1 diff
(99.9 %id)
BE148052 head_neck .vd-u 595 to 1111 522 to 5   tiling clone, Submitted on the opposite strand 518/678
(76 %)
0 diff
(100 %id)
BF884924 lung_tumor .vd-u 934 to 1169 13 to 248       236/253
(93 %)
10 diff
(96.1 %id)
CV571636 cornea, eye .vd-u 953 to 1499 1 to 547   tiling clone,   547/547
(100 %)
1 diff
(99.9 %id)
BF879412 lung_tumor .vd-u 1013 to 1536 1 to 525       525/533
(98 %)
20 diff
(96.3 %id)
AA093428   .vd-u 1069 to 1293 1 to 223       223/226
(98 %)
9 diff
(96.1 %id)
T96065 liver and spleen .vd-u 1098 to 1366 1 to 281   tiling clone, fully sequenced,   281/281
(100 %)
7 diff
(97.6 %id)
CK824702 Pancreas, Purified pancreatic islet .vd-u 1176 to 1602 1 to 427   tiling clone, Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
D29556   .vd-u 1323 to 1652 1 to 338       338/346
(97 %)
26 diff
(92.5 %id)
T96066 liver and spleen .vd-u 1336 to 1647 338 to 25   fully sequenced,   314/338
(92 %)
7 diff
(98.0 %id)
CD673159 eye, Iris .vd-u 1432 to 1807 1 to 376 S79X Y81X S93G S100F tiling clone,   376/376
(100 %)
8 diff
(97.9 %id)
EL594781 epidermis, skin .vd-u 1648 to 2170 42 to 565   tiling clone,   524/579
(90 %)
45 diff
(92.3 %id)
BF766866 colon_est .vd-u 1880 to 2040 14 to 175   tiling clone,   162/175
(92 %)
0 diff
(100 %id)
BF766988 colon_est .vd-u 1917 to 2191 14 to 288   tiling clone,   275/291
(94 %)
17 diff
(94.2 %id)
BF766864 colon_est .vd-u 2021 to 2268 1 to 249   tiling clone,   249/258
(96 %)
17 diff
(93.5 %id)
CN401052 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 3002 to 3651 1 to 650   tiling clone,   650/650
(100 %)
7 diff
(99.0 %id)
DA205203 brain .vd-u 3537 to 4086 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
DB315580 brain .vd-u 3596 to 4133 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
AI538363 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .vd-u 3726 to 4133 408 to 1   tiling clone,   408/408
(100 %)
1 diff
(99.8 %id)
DA518773 brain .ve 1 to 539 2 to 540 M8V tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
BF772994 epid_tumor .vf 1 to 231 248 to 19   tiling clone, Submitted on the opposite strand 230/248
(92 %)
0 diff
(100 %id)
AY180170   .vf 221 to 931 1 to 711 S141T tiling clone,   711/712
(99 %)
19 diff
(97.4 %id)
BP261062 small intestine .vg 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BG497797 adenocarcinoma, Prostate .vg 23 to 835 1 to 813 A118C I119H T120H F121L F122L ... tiling clone,   813/879
(92 %)
22 diff
(97.5 %id)
BF528062 anaplastic oligodendroglioma with 1p/19qloss, brain .vh 1 to 770 1 to 765 W6G I7* tiling clone,   765/765
(100 %)
6 diff
(99.3 %id)
CD709942 normal nasopharynx .vh 91 to 550 32 to 494       463/494
(93 %)
13 diff
(97.4 %id)
AA336706 endometrium .vh 121 to 340 1 to 220       220/220
(100 %)
0 diff
(100 %id)
BE778409 eye, retinoblastoma .vh 123 to 507 1 to 385       385/385
(100 %)
0 diff
(100 %id)
AA151008 uterus .vh 214 to 675 1 to 464   fully sequenced,   464/464
(100 %)
5 diff
(99.0 %id)
AA121006 uterus .vh 215 to 673 1 to 459   tiling clone, fully sequenced,   459/459
(100 %)
0 diff
(100 %id)
AA115938 uterus .vh 469 to 672 204 to 1   fully sequenced,   204/204
(100 %)
0 diff
(100 %id)
AA150836 uterus .vh 469 to 672 203 to 1   fully sequenced,   203/203
(100 %)
1 diff
(99.6 %id)
BX486790   .vi 1 to 442 6 to 447 Q30R tiling clone,   447/447
(100 %)
2 diff
(99.6 %id)
BG680533 skin, squamous cell carcinoma .vj-u 1 to 813 1 to 810 exact tiling clone,   810/817
(99 %)
6 diff
(99.3 %id)
AA421321 ovarian tumor, ovary .vj-u 495 to 550 56 to 1       56/56
(100 %)
0 diff
(100 %id)
BI011152 lung_normal .vj-u 625 to 1153 1 to 529   tiling clone,   529/529
(100 %)
5 diff
(99.1 %id)
BF806928 colon_ins .vj-u 661 to 1144 40 to 528       489/529
(92 %)
31 diff
(94.2 %id)
CA307841 Alveolar Macrophage, lung .vk 1 to 674 692 to 19 E16X G25X F28X tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 674/674
(100 %)
0 diff
(100 %id)
AW748465 breast .vk 359 to 979 1 to 623   tiling clone,   623/624
(99 %)
6 diff
(99.1 %id)
W42552 senescent fibroblast .vl 1 to 437 1 to 438 Y6X N8X W37I N38I Q39N ... tiling clone, fully sequenced,   438/438
(100 %)
12 diff
(97.3 %id)
BE091095 breast .vl 5 to 252 1 to 249   tiling clone,   245/259
(94 %)
10 diff
(96.2 %id)
BM856700 stomach .vl 208 to 483 58 to 333   tiling clone,   276/333
(82 %)
1 diff
(99.7 %id)
AI089477 uterus .vl 297 to 776 497 to 18   tiling clone, AAA   480/480
(100 %)
5 diff
(99.0 %id)
W42437 senescent fibroblast .vl 408 to 776 369 to 1   tiling clone, fully sequenced,   369/369
(100 %)
1 diff
(99.8 %id)
BM806191 leiomyosarcoma, uterus .vm 1 to 736 1 to 736 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 736/736
(100 %)
1 diff
(99.9 %id)
BQ000054 Fibrosarcoma .vn 1 to 722 740 to 19 G4X T25Q F41X tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 722/722
(100 %)
3 diff
(99.6 %id)
AY180168 Liver .vn 12 to 693 1 to 680   tiling clone,   680/689
(98 %)
3 diff
(99.6 %id)
BE048042 brain, tumor, 5 pooled (see description) .vn 134 to 693 1 to 561   fully sequenced,   561/561
(100 %)
8 diff
(98.6 %id)
CR998206 T-Lymphocytes .vn 145 to 719 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
DB338435 testis .vn 168 to 725 558 to 1   tiling clone,   558/558
(100 %)
3 diff
(99.5 %id)
TI_149306187   .vn 183 to 722 683 to 142   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 542/935
(57 %)
4 diff
(99.6 %id)
BU686253 lung, Primary Lung Epithelial Cells .vn 183 to 722 560 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 542/550
(98 %)
4 diff
(99.3 %id)
AI863270 brain, tumor, 5 pooled (see description) .vn 349 to 722 375 to 1   fully sequenced,   375/375
(100 %)
2 diff
(99.5 %id)
BM726829 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vo 1 to 380 1 to 380   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
BU741129 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vo 319 to 908 608 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 590/590
(100 %)
1 diff
(99.9 %id)
R35099 whole brain .vp 1 to 355 1 to 356   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 356/356
(100 %)
1 diff
(99.8 %id)
DT220410 brain .vp 32 to 629 1 to 598       598/598
(100 %)
0 diff
(100 %id)
AW089057 brain, tumor, 5 pooled (see description) .vp 114 to 613 501 to 1       501/518
(96 %)
16 diff
(97.0 %id)
AI879667 brain, frontal lobe .vp 153 to 635 488 to 6       483/488
(98 %)
5 diff
(99.0 %id)
TI_154132086   .vp 227 to 943 835 to 109   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 727/751
(96 %)
21 diff
(97.3 %id)
BM693561 eye, Retina Foveal and Macular .vp 341 to 885 1 to 545       545/545
(100 %)
0 diff
(100 %id)
R49486 whole brain .vp 614 to 950 367 to 22   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 346/346
(100 %)
16 diff
(95.4 %id)
CR619996 Placenta Cot 25-normalized .vq 1 to 782 1 to 782 exact tiling clone,   782/782
(100 %)
0 diff
(100 %id)
BX340258 Placenta Cot 25-normalized .vq 1 to 782 1 to 783 Q32X F104Y     783/783
(100 %)
2 diff
(99.8 %id)
BX391416 Placenta Cot 25-normalized .vq 1 to 782 1 to 790 A2X L11S R12C A13W G14A ...     790/790
(100 %)
12 diff
(98.5 %id)
TI_45211097   .vq 15 to 957 84 to 1038       955/1040
(91 %)
43 diff
(95.9 %id)
CN261581 embryonic stem cells, DMSO-treated H9 cellline .vq 18 to 579 9 to 570       562/570
(98 %)
3 diff
(99.5 %id)
BI598780 brain, hypothalamus .vq 19 to 957 1 to 951       951/953
(99 %)
42 diff
(95.6 %id)
AA448994   .vq 20 to 544 1 to 522       522/522
(100 %)
11 diff
(97.9 %id)
BU956674 adenocarcinoma, cell line, breast .vq 22 to 883 1 to 876   tiling clone,   876/890
(98 %)
14 diff
(98.5 %id)
AA058608 uterus .vq 29 to 457 12 to 440   fully sequenced,   429/440
(97 %)
1 diff
(99.8 %id)
BF195110 brain, glioblastoma (pooled) .vq 243 to 782 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BF197057 brain, glioblastoma (pooled) .vq 254 to 782 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
AA053312 uterus .vq 405 to 782 395 to 16   fully sequenced, AAA   380/380
(100 %)
2 diff
(99.5 %id)
AA449460   .vq 777 to 1151 376 to 2   tiling clone,   375/376
(99 %)
0 diff
(100 %id)
CA310129 Alveolar Macrophage, lung .vr 1 to 629 653 to 16 Q28X S30K I31Y S32L E33R ... tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 635/635
(100 %)
5 diff
(99.3 %id)
CD368426 Alveolar Macrophage, lung .vr 2 to 629 648 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 630/630
(100 %)
2 diff
(99.7 %id)
AY180169   .vs 1 to 972 1 to 972 exact tiling clone,   972/972
(100 %)
2 diff
(99.8 %id)
AI445348 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vt-u 1 to 264 1 to 264   tiling clone, Submitted on the opposite strand 264/264
(100 %)
0 diff
(100 %id)
BE151514 head_neck .vt-u 155 to 293 147 to 11     Submitted on the opposite strand 137/150
(91 %)
0 diff
(100 %id)
CD177672 testis .vt-u 177 to 1025 36 to 886   tiling clone,   851/887
(95 %)
5 diff
(99.5 %id)
BQ187729 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vt-u 251 to 785 29 to 562       534/562
(95 %)
0 diff
(100 %id)
C21052   .vt-u 255 to 339 85 to 1       85/85
(100 %)
0 diff
(100 %id)
CR738284 liver and spleen .vt-u 312 to 537 1 to 227       227/227
(100 %)
1 diff
(99.6 %id)
CR738286 liver and spleen .vt-u 312 to 520 1 to 209       209/209
(100 %)
8 diff
(96.2 %id)
T95495 liver and spleen .vt-u 312 to 595 1 to 289   fully sequenced,   289/289
(100 %)
3 diff
(99.0 %id)
CA397161 eye, RPE/choroid .vt-u 328 to 704 1 to 377       377/377
(100 %)
6 diff
(98.5 %id)
BM563108 brain, medulla .vt-u 341 to 1278 21 to 958 W31Y L32G G33W A34V V35R ... tiling clone,   938/1141
(82 %)
0 diff
(100 %id)
AW467516 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .vt-u 429 to 905 482 to 6       477/482
(98 %)
0 diff
(100 %id)
AI801922 Prostate .vt-u 536 to 897 367 to 6       362/367
(98 %)
0 diff
(100 %id)
BF477606 Prostate .vt-u 563 to 897 339 to 5       335/339
(98 %)
0 diff
(100 %id)
T95496 liver and spleen .vt-u 565 to 878 328 to 1   fully sequenced,   328/328
(100 %)
3 diff
(99.1 %id)
CN403626 embryonic stem cells, DMSO-treated H9 cellline .vt-u 689 to 897 1 to 209       209/211
(99 %)
1 diff
(99.6 %id)
AW402975 lymph .vt-u 923 to 1295 1 to 367   tiling clone,   367/367
(100 %)
11 diff
(97.1 %id)
TI_154139504   .vt-u 936 to 1571 82 to 718       637/637
(100 %)
18 diff
(97.2 %id)
CR986249 T-Lymphocytes .vt-u 941 to 1706 1 to 760       760/766
(99 %)
14 diff
(98.2 %id)
CN403627 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vt-u 942 to 1530 1 to 590       590/590
(100 %)
8 diff
(98.7 %id)
DR762128 embryonic stem .vt-u 1071 to 1827 1 to 753   tiling clone,   753/753
(100 %)
6 diff
(99.3 %id)
BQ279029 adenocarcinoma, cell line, breast .vt-u 1314 to 1825 1 to 509       509/536
(94 %)
7 diff
(98.7 %id)
BU957158 adenocarcinoma, cell line, breast .vt-u 1314 to 1840 1 to 528   tiling clone,   528/532
(99 %)
5 diff
(99.1 %id)
BG402781 bladder, transitional cell papilloma, cell line .vt-u 1358 to 1842 1 to 486   tiling clone,   486/913
(53 %)
7 diff
(99.3 %id)
BG762364 melanotic melanoma, high MDR (cell line), skin .vt-u 1366 to 1829 1 to 466   tiling clone,   466/789
(59 %)
5 diff
(99.4 %id)
TI_154171187   .vt-u 1391 to 1955 80 to 636   tiling clone,   557/557
(100 %)
7 diff
(98.8 %id)
CF140618 CNCAP(3)T-225 cell line, Prostate .vt-u 1392 to 1855 1 to 464   tiling clone,   464/464
(100 %)
11 diff
(97.7 %id)
BQ054262 blood, natural killer cells, cell line .vt-u 1413 to 1842 1 to 431   tiling clone,   431/1250
(34 %)
5 diff
(99.6 %id)
CB159496 Liver .vt-u 1600 to 1828 45 to 273       229/273
(83 %)
0 diff
(100 %id)
BQ943388 brain, neuroblastoma, cell line .vt-u 1857 to 2721 1 to 871   tiling clone,   871/961
(90 %)
29 diff
(97.0 %id)
AW062329 colon .vt-u 1872 to 2528 23 to 678       656/800
(82 %)
33 diff
(95.9 %id)
CV570134 cornea, eye .vt-u 1901 to 2372 1 to 471       471/471
(100 %)
9 diff
(98.1 %id)
BG483448 lung .vt-u 1926 to 2665 1 to 735   tiling clone,   735/744
(98 %)
45 diff
(94.0 %id)
BG925549 cartilage .vt-u 1943 to 2311 76 to 445       370/379
(97 %)
6 diff
(98.5 %id)
BM796045 Ascites, stomach .vt-u 1946 to 2300 1 to 355       355/355
(100 %)
7 diff
(98.1 %id)
BX472951   .vt-u 2002 to 2417 1 to 416       416/416
(100 %)
5 diff
(98.8 %id)
CA426758 cell lines, Chondrosarcoma .vt-u 2088 to 2886 813 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 795/796
(99 %)
10 diff
(98.8 %id)
BY799483 eye .vt-u 2094 to 2671 1 to 579       579/579
(100 %)
7 diff
(98.8 %id)
AW136943   .vt-u 2102 to 2203 117 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 102/103
(99 %)
1 diff
(99.1 %id)
BX119636 lung .vt-u 2111 to 2433 1 to 329       329/329
(100 %)
8 diff
(97.6 %id)
W07379 lung .vt-u 2111 to 2327 1 to 217       217/217
(100 %)
3 diff
(98.7 %id)
CR737034 lung .vt-u 2112 to 2587 1 to 477       477/479
(99 %)
5 diff
(99.0 %id)
W70164 heart .vt-u 2135 to 2555 1 to 425       425/425
(100 %)
7 diff
(98.4 %id)
CA428426 Bone, Subchondral Bone .vt-u 2173 to 2881 737 to 28   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 710/710
(100 %)
3 diff
(99.6 %id)
TI_149294223   .vt-u 2176 to 2886 799 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 712/713
(99 %)
4 diff
(99.5 %id)
AA007657 liver and spleen .vt-u 2185 to 2406 1 to 220   fully sequenced,   220/220
(100 %)
5 diff
(97.8 %id)
BG683610 brain, neuroblastoma, cell line .vt-u 2186 to 2834 652 to 1       652/656
(99 %)
6 diff
(99.1 %id)
CA313904 Human Lung Epithelial cells, lung .vt-u 2191 to 2886 715 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 697/697
(100 %)
4 diff
(99.5 %id)
BU683017 lung .vt-u 2196 to 2886 710 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 692/692
(100 %)
4 diff
(99.5 %id)
BQ009680 Chondrosarcoma, Left Pubic Bone .vt-u 2200 to 2886 706 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 688/688
(100 %)
11 diff
(98.5 %id)
BQ001264 lung, Metastatic Chondrosarcoma .vt-u 2216 to 2897 701 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 683/698
(97 %)
1 diff
(99.9 %id)
BM931784 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vt-u 2216 to 2878 1 to 663   tiling clone, fully sequenced,   663/663
(100 %)
7 diff
(99.0 %id)
AW998500 breast_normal .vt-u 2240 to 2463 1 to 225       225/225
(100 %)
9 diff
(96.0 %id)
AA328482   .vt-u 2252 to 2577 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
AA328483   .vt-u 2252 to 2558 1 to 309       309/316
(97 %)
5 diff
(98.5 %id)
AW952452   .vt-u 2253 to 2807 1 to 556       556/557
(99 %)
4 diff
(99.3 %id)
CA309122 Alveolar Macrophage, lung .vt-u 2298 to 2886 608 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 590/590
(100 %)
3 diff
(99.5 %id)
AA706790 liver and spleen .vt-u 2303 to 2886 585 to 1       585/585
(100 %)
4 diff
(99.4 %id)
BM987383 Bone, Subchondral Bone .vt-u 2309 to 2880 590 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 572/592
(96 %)
4 diff
(99.4 %id)
CB163053 Liver .vt-u 2325 to 2581 1 to 258       258/258
(100 %)
4 diff
(98.5 %id)
BM719509 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vt-u 2337 to 2881 1 to 546   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 546/546
(100 %)
2 diff
(99.7 %id)
BQ671953 epidermoid carcinoma, cell line, salivary gland .vt-u 2338 to 2881 1 to 545   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 545/545
(100 %)
1 diff
(99.9 %id)
AI697948 carcinoid, lung .vt-u 2357 to 2885 527 to 1       527/527
(100 %)
4 diff
(99.3 %id)
AI818367 adenocarcinoma, Pancreas .vt-u 2360 to 2881 523 to 1       523/523
(100 %)
2 diff
(99.7 %id)
AI858617 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vt-u 2375 to 2886 513 to 1       513/513
(100 %)
1 diff
(99.9 %id)
AA007658 liver and spleen .vt-u 2376 to 2887 508 to 1   fully sequenced,   508/508
(100 %)
12 diff
(97.7 %id)
BF196583 brain, glioblastoma (pooled) .vt-u 2382 to 2886 506 to 1       506/506
(100 %)
1 diff
(99.9 %id)
AI571759 anaplastic oligodendroglioma, brain .vt-u 2395 to 2881 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
AI096775 brain, glioblastoma (pooled) .vt-u 2396 to 2887 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
BE328847 carcinoid, lung .vt-u 2398 to 2885 489 to 1       489/489
(100 %)
1 diff
(99.8 %id)
AW519131 adenocarcinoma, Pancreas .vt-u 2411 to 2890 481 to 1       481/481
(100 %)
2 diff
(99.6 %id)
AA733044 heart .vt-u 2414 to 2887 477 to 2       476/477
(99 %)
0 diff
(100 %id)
BG231736 blood, lymphocyte .vt-u 2414 to 2881 479 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 469/469
(100 %)
2 diff
(99.6 %id)
N80253 lung .vt-u 2434 to 2897 461 to 1       461/462
(99 %)
15 diff
(96.8 %id)
AI363365 brain, glioblastoma (pooled) .vt-u 2438 to 2886 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AI123638 pooled .vt-u 2444 to 2890 452 to 5       448/452
(99 %)
0 diff
(100 %id)
AA946988 2 pooled tumors (clear cell type), Kidney .vt-u 2452 to 2882 434 to 3       432/434
(99 %)
0 diff
(100 %id)
AI126856 heart .vt-u 2452 to 2888 461 to 24   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 438/438
(100 %)
2 diff
(99.6 %id)
AW015811   .vt-u 2459 to 2880 440 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 423/426
(99 %)
2 diff
(99.6 %id)
BM675573 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vt-u 2472 to 2878 428 to 21   fully sequenced,   408/428
(95 %)
2 diff
(99.6 %id)
AI571898 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vt-u 2477 to 2887 412 to 1       412/414
(99 %)
1 diff
(99.8 %id)
AI962208 pooled germ cell tumors .vt-u 2477 to 2886 430 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 412/412
(100 %)
13 diff
(96.9 %id)
AI365427 B-cell, chronic lymphotic leukemia .vt-u 2479 to 2882 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AW339376 carcinoid, lung .vt-u 2479 to 2885 418 to 1       418/418
(100 %)
14 diff
(96.7 %id)
AI651148 pooled germ cell tumors .vt-u 2493 to 2880 392 to 4       389/392
(99 %)
0 diff
(100 %id)
AI970105 pooled germ cell tumors .vt-u 2493 to 2880 393 to 4       390/393
(99 %)
0 diff
(100 %id)
BE502405 pooled germ cell tumors .vt-u 2493 to 2880 395 to 7       389/395
(98 %)
0 diff
(100 %id)
BE502665 pooled germ cell tumors .vt-u 2493 to 2880 392 to 4       389/392
(99 %)
0 diff
(100 %id)
AI079735 brain, glioblastoma (pooled) .vt-u 2499 to 2887 390 to 1       390/390
(100 %)
9 diff
(97.7 %id)
AI983461 adenocarcinoma, Pancreas .vt-u 2508 to 2731 235 to 11       225/235
(95 %)
0 diff
(100 %id)
BG230743 blood, lymphocyte .vt-u 2528 to 2886 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
BG911231 anaplastic oligodendroglioma with 1p/19qloss, brain .vt-u 2532 to 2881 9 to 356   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 348/356
(97 %)
0 diff
(100 %id)
BU194839 melanotic melanoma, skin .vt-u 2535 to 2886 1 to 353   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 353/353
(100 %)
1 diff
(99.8 %id)
AA040945 uterus .vt-u 2543 to 2897 383 to 28   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 356/356
(100 %)
1 diff
(99.8 %id)
CA428142 Bone, Subchondral Bone .vt-u 2550 to 2886 356 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 338/344
(98 %)
2 diff
(99.5 %id)
AI680295 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .vt-u 2572 to 2882 312 to 2       311/312
(99 %)
0 diff
(100 %id)
W70106 heart .vt-u 2573 to 2890 317 to 1       317/317
(100 %)
4 diff
(98.8 %id)
AI289637 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vt-u 2585 to 2886 321 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 303/303
(100 %)
4 diff
(98.7 %id)
AA983291 2 pooled tumors (clear cell type), Kidney .vt-u 2600 to 2890 294 to 3       292/294
(99 %)
0 diff
(100 %id)
BE501199 pooled germ cell tumors .vt-u 2671 to 2880 211 to 1       211/212
(99 %)
3 diff
(98.6 %id)
AI034089 liver and spleen .vt-u 2680 to 2886 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
AI699558 pooled germ cell tumors .vt-u 2684 to 2880 201 to 4       198/201
(98 %)
0 diff
(100 %id)
AW089402 brain, tumor, 5 pooled (see description) .vt-u 2723 to 2887 166 to 2       165/166
(99 %)
0 diff
(100 %id)
AA777847 liver and spleen .vt-u 2731 to 2886 156 to 1       156/156
(100 %)
1 diff
(99.4 %id)
BQ004729 Chondrosarcoma, Left Pelvis .vu 1 to 689 709 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
BX119699   .vv 1 to 652 1 to 652 exact tiling clone, AAA   652/652
(100 %)
0 diff
(100 %id)
AA813102   .vv 130 to 653 524 to 1       524/524
(100 %)
6 diff
(98.9 %id)
AA884872 pooled .vv 222 to 481 260 to 1       260/260
(100 %)
0 diff
(100 %id)
AW592043 pooled .vv 235 to 653 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AA759091   .vv 248 to 653 408 to 3       406/408
(99 %)
0 diff
(100 %id)
AA609266   .vv 256 to 650 401 to 7       395/401
(98 %)
0 diff
(100 %id)
AA620956   .vv 256 to 653 399 to 3       397/399
(99 %)
1 diff
(99.8 %id)
AI017202 pooled .vv 279 to 648 377 to 8       370/377
(98 %)
0 diff
(100 %id)
BQ353952 head_neck .vw-u 1 to 278 278 to 1   tiling clone,   278/308
(90 %)
6 diff
(98.1 %id)
AK024714   .vw-u 34 to 2124 1 to 2093 C29S tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2093/2093
(100 %)
10 diff
(99.6 %id)
BE093618 breast .vw-u 199 to 437 1 to 237   tiling clone,   237/237
(100 %)
2 diff
(99.2 %id)
T26557   .vw-u 758 to 1076 320 to 2     Submitted on the opposite strand 319/322
(99 %)
0 diff
(100 %id)
BF325939 amnion_normal .vw-u 825 to 1343 519 to 1   tiling clone,   519/519
(100 %)
3 diff
(99.5 %id)
BQ002171 Chondrosarcoma, Left Pelvis .vw-u 1589 to 2126 554 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 538/538
(100 %)
0 diff
(100 %id)
AW896995 nervous_normal .vw-u 1618 to 1745 1 to 129       129/130
(99 %)
3 diff
(97.7 %id)
AV762149 bone marrow .vw-u 1628 to 2125 1 to 498       498/757
(65 %)
6 diff
(99.3 %id)
BF510886   .vw-u 1674 to 2126 470 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 453/453
(100 %)
1 diff
(99.8 %id)
AI288992 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vw-u 1700 to 2125 427 to 2       426/427
(99 %)
0 diff
(100 %id)
AI346392 adenocarcinoma, colon .vw-u 1700 to 2123 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
BP396130 pancreatic islet .vw-u 1773 to 2125 1 to 353     Submitted on the opposite strand 353/353
(100 %)
1 diff
(99.8 %id)
BU570003 testis .vx 1 to 696 1 to 696 I7V tiling clone, AAA   696/696
(100 %)
11 diff
(98.5 %id)
DA813809   .vy-u 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
CN275424 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vy-u 403 to 550 1 to 148   tiling clone,   148/148
(100 %)
0 diff
(100 %id)
AK125022 thalamus .vy-u 665 to 3941 1 to 3277 A67V tiling clone, available from FLJ,   3277/3277
(100 %)
21 diff
(99.4 %id)
DA398933 thalamus .vy-u 666 to 1242 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB327620   .vy-u 1655 to 2235 581 to 1 A67V     581/581
(100 %)
3 diff
(99.5 %id)
AK097119 Spleen .vy-u 1773 to 3941 1 to 2172 Q69R I86V tiling clone, available from FLJ,   2172/2172
(100 %)
21 diff
(99.1 %id)
BF367676 placenta_normal .vy-u 2515 to 2658 1 to 144       144/144
(100 %)
0 diff
(100 %id)
TI_154093037   .vy-u 2961 to 3455 89 to 583     Submitted on the opposite strand 495/583
(84 %)
0 diff
(100 %id)
DB312043 thalamus .vy-u 3408 to 3941 534 to 1       534/534
(100 %)
16 diff
(97.1 %id)
AL133587 testis .vz 1 to 1150 1 to 1149 G84A C85V R86G L87* tiling clone, available from DKFZ,   1149/1157
(99 %)
6 diff
(99.5 %id)
BP396581 pancreatic islet .vz 593 to 1015 1 to 423   tiling clone, Submitted on the opposite strand 423/427
(99 %)
3 diff
(99.3 %id)
AI703377 carcinoid, lung .vz 667 to 1148 482 to 1       482/482
(100 %)
2 diff
(99.6 %id)
AA713665 germinal center B cell .vz 696 to 1150 459 to 9       451/459
(98 %)
1 diff
(99.8 %id)
BE466288 malignant melanoma, metastatic to lymphnode, skin .vz 704 to 1150 448 to 2   tiling clone,   447/448
(99 %)
0 diff
(100 %id)
BG058591 blood, lymphocyte .wa 1 to 519 524 to 6   tiling clone,   519/524
(99 %)
0 diff
(100 %id)
AW363864 colon .wa 210 to 467 280 to 9       272/326
(83 %)
6 diff
(98.2 %id)
CK003856 brain/CNS, Human Brain - Cerebellar Cortex .wa 210 to 847 1 to 637 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/638
(99 %)
3 diff
(99.6 %id)
CK002826 brain/CNS, Human Brain - Cerebellar Cortex .wa 210 to 848 1 to 639 exact     639/644
(99 %)
5 diff
(99.3 %id)
BE263798 lung, small cell carcinoma .wa 219 to 848 1 to 630 exact tiling clone,   630/637
(98 %)
2 diff
(99.7 %id)
AA136691   .wb-u 1 to 429 1 to 444   tiling clone, fully sequenced,   444/444
(100 %)
24 diff
(94.6 %id)
BG994488 head_neck .wb-u 79 to 632 1 to 557   tiling clone,   557/557
(100 %)
12 diff
(97.9 %id)
AA136734   .wb-u 399 to 806 408 to 1 exact tiling clone, fully sequenced,   408/408
(100 %)
3 diff
(99.3 %id)
BP297295   .wc 1 to 580 1 to 581 exact tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BP204024 coronary artery .wc 7 to 588 1 to 582 exact tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
BP370896 testis .wc 7 to 575 1 to 569 exact     569/572
(99 %)
2 diff
(99.7 %id)
DA166947 amygdala .wc 23 to 585 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
BG392602 embryonal carcinoma, cell line, testis .wc 41 to 796 1 to 754 exact tiling clone,   754/754
(100 %)
7 diff
(99.1 %id)
BG437626 large cell carcinoma, lung .wd 1 to 740 1 to 738 exact tiling clone,   738/738
(100 %)
3 diff
(99.6 %id)
CR997181 T-Lymphocytes .we 1 to 719 1 to 719 exact tiling clone,   719/723
(99 %)
8 diff
(98.9 %id)
AU134021 ovary, tumor tissue .wf-u 1 to 693 2 to 694 exact tiling clone, capped   693/693
(100 %)
6 diff
(99.2 %id)
DA949261 Spleen .wg 1 to 558 2 to 560 exact tiling clone, capped   559/559
(100 %)
3 diff
(99.5 %id)
DA684616   .wh 1 to 539 2 to 540 E25K tiling clone, capped   539/539
(100 %)
2 diff
(99.7 %id)
CN358507 embryonic stem cells, DMSO-treated H9 cellline .wi 1 to 535 536 to 0 exact tiling clone, Submitted on the opposite strand 536/560
(95 %)
2 diff
(99.7 %id)
CD674947 eye, lens .wj 1 to 515 1 to 515 exact tiling clone,   515/515
(100 %)
0 diff
(100 %id)
AI934610 anaplastic oligodendroglioma, brain .wj 14 to 509 496 to 1 exact     496/496
(100 %)
0 diff
(100 %id)
H11800 whole brain .wk 1 to 513 1 to 526 A6P P9X V12C L13S H14A ... tiling clone,   526/528
(99 %)
24 diff
(95.5 %id)
DA104012 cerebellum .wl-u 1 to 330 2 to 331 S75L tiling clone, capped   330/330
(100 %)
3 diff
(99.1 %id)
AA482956 alveolar rhabdomyosarcoma .wm-u 1 to 236 279 to 45 exact tiling clone,   235/286
(82 %)
0 diff
(100 %id)
C18012 placenta Gene C14orf153andKLC1, variant not shown              
AA298653 synovial membrane Gene C14orf153andKLC1, variant not shown              
AA311087   Gene C14orf153andKLC1, variant not shown              
AK024310 ovary, tumor tissue Gene C14orf153andKLC1, variant not shown       available from FLJ, This clone was ignored    
AK091415 brain Gene C14orf153andKLC1, variant not shown       available from FLJ, This clone was ignored    
AX746968   Gene C14orf153andKLC1, variant not shown         This clone was ignored    
AY180167 superior frontal cortex Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
BE711790 head_neck Gene C14orf153andKLC1, variant not shown              
BG003944 placenta_normal Gene C14orf153andKLC1, variant not shown         This clone was ignored    
AL043408 testis Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
AL043409 testis Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
BX505087   Gene C14orf153andKLC1, variant not shown              
D79124 placenta Gene C14orf153andKLC1, variant not shown              
DB448124 testis Gene C14orf153andKLC1, variant not shown              
W37500 parathyroid gland, parathyroid tumor Gene C14orf153andKLC1, variant not shown         This clone was ignored    
W37596 parathyroid gland, parathyroid tumor Gene C14orf153andKLC1, variant not shown         This clone was ignored    
AI027409 parathyroid gland, parathyroid tumor Gene C14orf153andKLC1, variant not shown       AAA This clone was ignored    
AI973281 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
AW249492 lung, small cell carcinoma Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
AW250258 lung, small cell carcinoma Gene C14orf153andKLC1, variant not shown         Suspected internal deletion, this clone was ignored    
CK824703 Pancreas, Purified pancreatic islet Gene C14orf153andKLC1, variant not shown         Submitted on the opposite strand    
BP317962 pericardium Gene C14orf153andKLC1, variant not shown         This clone was ignored    
TI_227712841   Gene C14orf153andKLC1, variant not shown         This clone was ignored    
DB177271 kidney, tumor tissue Gene C14orf153andKLC1, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u, .vd-u, .ve, .vf, .vg, .vh, .vi, .vj-u, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt-u, .vu, .vv, .vw-u, .vx, .vy-u, .vz, .wa, .wb-u, .wc, .wd, .we, .wf-u, .wg, .wh, .wi, .wj, .wk, .wl-u, .wm-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI